Tyler Frederick Werbel

Tyler Werbel practices at Dermatologist Medical Group of North County, Inc in Oceanside, California.

Tyler Werbel's NPI, 1154881589, was assigned on March 21, 2019. Tyler Werbel graduated from UC San Diego School of Medicine in 2019. Tyler Werbel holds Florida license ME162011.

Tyler Werbel's primary practice is Dermatologist Medical Group of North County, Inc, at 3613 Vista Way, Oceanside, CA 92056 in San Diego County. The practice phone is (760) 758-5340.

Tyler Werbel's primary practice is Dermatologist Medical Group of North County, Inc in Oceanside, California. Tyler Werbel is also affiliated with UF Health Shands Hospital. The medical group on file is Dermatologist Medical Group of North County. Dmand AI also links Tyler Werbel to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tyler Werbel practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Tyler Werbel's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Tyler Werbel is board certified in dermatology by the American Board of Dermatology. Dmand AI has Tyler Werbel's licenses on file in 3 states: Florida, Oregon and California.

CMS data shows 911 Medicare services from Tyler Werbel across 16 procedure codes in 2024, for 328 Medicare patients. Medicare paid $123,627 for them. Every service was in an office.

CMS counts 328 Medicare patients who saw Tyler Werbel in 2024. The largest group is 75 to 84, with 139 patients. 72% of them have high cholesterol, and 59% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Tyler Werbel's median patient age at 62, with 41% women.

In 2024, Tyler Werbel wrote 286 Medicare Part D claims for 195 patients. 95% of them were for generic drugs. CMS names the drug for 206 of them, across 9 drugs with 11 or more claims each, at $5,346 in total drug cost. In 2023, CMS named 115 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Tyler Werbel for performance year 2024, reported as part of a group. Tyler Werbel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 117 procedures of melanoma (skin cancer) excision by Tyler Werbel, more than 94% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 18 papers to Tyler Werbel, published from 2018 to 2024. 2018 was the busiest year, with 6. The most frequent topics are Cells, Cultured, Erythema and Lysophospholipids. Tyler Werbel has published most often in Cureus. Tyler Werbel's most frequent co-authors are Philip R. Cohen, MD, Anna Di Nardo, MD and Sailesh Konda, MD.

CMS Open Payments shows 77 general payments to Tyler Werbel from 20 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 98% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $741.

Tyler Werbel graduated from UC San Diego School of Medicine in 2019.

Tyler Werbel is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.